Emergent BioSolutions announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial terms expiring at Emergent’s 2024 Annual Meeting of Stockholders. Both joined as independent directors and bring more than 70 years of combined biopharmaceutical industry and sales experience. Fowler will serve on the Audit and Finance Committee, and DeGolyer will serve on the Compensation Committee.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EBS:
- Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
- Emergent BioSolutions falls -5.8%
- Emergent BioSolutions rises 4.5%
- Biotech Alert: Searches spiking for these stocks today
- Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
